Sana Biotechnology Inc (SANA)
7.97
-0.29
(-3.51%)
USD |
NASDAQ |
May 23, 16:00
7.97
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Price to Book Value: 4.706 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 4.877 |
| May 21, 2024 | 4.901 |
| May 20, 2024 | 5.096 |
| May 17, 2024 | 5.155 |
| May 16, 2024 | 5.048 |
| May 15, 2024 | 5.474 |
| May 14, 2024 | 5.078 |
| May 13, 2024 | 4.670 |
| May 10, 2024 | 4.464 |
| May 09, 2024 | 4.428 |
| May 08, 2024 | 5.603 |
| May 07, 2024 | 5.928 |
| May 06, 2024 | 5.904 |
| May 03, 2024 | 6.164 |
| May 02, 2024 | 5.770 |
| May 01, 2024 | 5.681 |
| April 30, 2024 | 5.310 |
| April 29, 2024 | 5.357 |
| April 26, 2024 | 5.145 |
| April 25, 2024 | 5.015 |
| April 24, 2024 | 5.062 |
| April 23, 2024 | 4.773 |
| April 22, 2024 | 4.678 |
| April 19, 2024 | 4.490 |
| April 18, 2024 | 4.560 |
| Date | Value |
|---|---|
| April 17, 2024 | 4.873 |
| April 16, 2024 | 4.962 |
| April 15, 2024 | 5.044 |
| April 12, 2024 | 5.286 |
| April 11, 2024 | 5.522 |
| April 10, 2024 | 5.310 |
| April 09, 2024 | 5.510 |
| April 08, 2024 | 5.363 |
| April 05, 2024 | 5.314 |
| April 04, 2024 | 5.020 |
| April 03, 2024 | 5.403 |
| April 02, 2024 | 5.202 |
| April 01, 2024 | 5.969 |
| March 28, 2024 | 7.668 |
| March 27, 2024 | 7.668 |
| March 26, 2024 | 7.254 |
| March 25, 2024 | 6.970 |
| March 22, 2024 | 7.016 |
| March 21, 2024 | 7.016 |
| March 20, 2024 | 6.862 |
| March 19, 2024 | 6.632 |
| March 18, 2024 | 6.832 |
| March 15, 2024 | 6.809 |
| March 14, 2024 | 6.939 |
| March 13, 2024 | 7.553 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.075
Minimum
Dec 27 2022
8.641
Maximum
Mar 01 2024
3.080
Average
2.522
Median
Jul 19 2022
Price to Book Value Benchmarks
| Rocket Pharmaceuticals Inc | 4.470 |
| Solid Biosciences Inc | 1.421 |
| Dyne Therapeutics Inc | 5.713 |
| Taysha Gene Therapies Inc | 10.25 |
| Tenaya Therapeutics Inc | 2.159 |
Price to Book Value Related Metrics
| Price | 7.97 |
| Earnings Yield | -19.20% |
| Market Cap | 1.765B |